# Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation

**Authors:** Nabeel Mansour, Kathrin Heinrich, Danmei Zhang, Michael Winkelmann, Maria Ingenerf, Lukas Gold, Konstantin Klambauer, Martina Rudelius, Frederick Klauschen, Michael von Bergwelt-Baildon, Jens Ricke, Volker Heinemann, C. Benedikt Westphalen, Wolfgang G. Kunz

PMC · DOI: 10.1186/s40644-024-00724-5 · 2024-07-01

## Full-text entities

- **Diseases:** tumor (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC11218213